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Herpes simplex virus type 1 (HSV-1) infection disrupted cell cycle regulation in at least two ways. First, infection of
quiescent human embryonic lung cells simultaneously with readdition of serum caused inhibition of cyclin D/cyclin-
dependent kinase (CDK) 4,6-specific and cyclin E/CDK2-specific phosphorylation of the retinoblastoma protein pRb. The
inhibition of cyclin D/CDK4,6 kinase activity corresponded to a loss of cyclin D1 protein and a failure of CDK4 and CDK6 to
translocate to the nucleus. Failure to detect cyclin E/CDK2 kinase activity was accompanied by a loss of cyclin E protein and
a failure of CDK2 to translocate to the nucleus. Levels of pocket protein p130 persisted, whereas p107 did not accumulate.
As a result of these effects on cyclin kinase, G0-infected cells failed to reenter the cell cycle. The second type of HSV-induced
cell cycle dysregulation was observed in asynchronously dividing cell cultures. A rapid inhibition of preexisting cyclin E/CDK2
and cyclin A/CDK2 activities was observed in human embryonic lung cells, as well as two other human cell lines: C33 and
U2OS. HSV-1 immediate-early gene expression was necessary for the inhibition of CDK2 kinase activity. Cyclin and CDK
subunit protein levels, intracellular localization, and complex stability were unaffected by infection. In addition, levels of
cyclin-dependent kinase inhibitors, p27 and p21, were not affected by HSV-1. Previous experiments demonstrated that in
asynchronous infected cells, hypophosphorylated pRb and pocket protein–E2F complexes accumulated, and cellular DNA
synthesis was rapidly inhibited. Coupled with the present results, this indicates that HSV-1 has evolved mechanisms for
preventing cells in G1 from proceeding through the restriction point and for cells in S from completing a round of DNA
replication. © 2000 Academic Press
Key Words: herpes simplex virus type 1; retinoblastoma protein; CDk4; CDk6; CDK2; cyclin E; cyclin D; cell cycle.
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A family of cyclin-dependent kinases (CDKs) is re-
sponsible for the orderly progression of cells through the
cell cycle. Cyclin D/CDK4,6 and cyclin E/CDK2 are nec-
essary for progression through G1 phase. Cyclin E/CDK2
ctivity increases during mid-G1 phase and is thought to
target functions necessary for the initiation of DNA rep-
lication (Sauer and Lehner, 1995), driving cells to late G1
phase and across the G1/S boundary. Both cyclin
/CDK4,6 and cyclin E/CDK2 activities are known to be
ate limiting for G1 phase progression, as overexpression
of these kinases resulted in a shortened G1 phase
(Resnitsky and Reed, 1995). Cyclin A expression in-
creases in an E2F-dependent manner in late G1 phase
Liu et al., 1998). Cyclin A/CDK2 kinase activity is rate
imiting for the initiation of S phase (Resnitzky et al., 1995)
nd is necessary for activities throughout S phase (Des-
ouets et al., 1995). In late S phase, cyclin A/CDK2
omplexes are replaced by cyclin A/CDC2 and cyclin
/CDC2 complexes. These kinases regulate the S/G2
transition and finally carry cells into M phase.
1 To whom reprint requests should be addressed at 837 Jones, CB
7290. Fax: (919) 962-8103. E-mail: bachlab@med.unc.edu.
335Binding of the catalytic cyclin-dependent kinase sub-
unit to its corresponding regulatory cyclin subunit and a
subsequent activating phosphorylation event allow for
the phosphorylation of target proteins. One such target
protein is the E2F-inhibitory protein, pRb (Pines, 1995;
Sherr, 1994, 1996). Phosphorylation of pRb is critical to
the progression of cells from G1 to S (Mittnacht, 1998).
uring G0 and early G1, pRb exists in an unphosphory-
lated state complexed with the E2F transcription factor.
As cells progress through G1, pRb is sequentially phos-
horylated by cyclin D/CDK4,6 and cyclin E/CDK2
Ezhevsky et al., 1997; Knudsen and Wang, 1997; Lund-
erg and Weinberg, 1998). Once hyperphosphorylated,
Rb releases E2F, resulting in the transcription of E2F-
esponsive genes necessary for the initiation of DNA
eplication in S phase. Included among these are genes
ncoding cyclin A, cdc2, DNA polymerase a, and thymi-
dine kinase (Dyson, 1998).
The effects of an alphaherpesvirus, herpes simplex
virus (HSV), infection on cell cycle regulation are not
precisely understood. Although it is known that HSV
encodes proteins essential for replication of viral DNA, at
least one cell cycle-regulated function can enhance rep-
lication of a mutant virus. Specifically, a cellular function
present during the transition from G0 to late G1 can
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
c
(
t
i
p
e
d
d
s
r
r
D
(
o
a
c
t
H
p
c
G
p
1
p
t
l
a
g
a
p
t
i
c
f
r
H
k
(
c
b
p
n
G
c
m
n
o
t
g
D
t
S
0
D
s
p
a
336 EHMANN, MCLEAN, AND BACHENHEIMERcomplement an ICP0-deficient virus, allowing for activa-
tion of viral gene expression in the absence of the viral
encoded transactivator (Cai and Schaffer, 1991). Interest-
ingly, interactions between the viral protein ICP0 and cell
cycle protein cyclin D3 have also been observed
(Kawaguchi et al., 1997; Van Sant et al., 1999). More
recent studies have suggested that wild-type (WT) HSV
requires the activities of G1-specific cellular proteins to
reate an environment favorable for WT viral replication
Hossain et al., 1997; Schang et al., 1998). In one, infec-
ion of serum-arrested CV-1 cells with HSV-2 revealed an
nduction of CDK2-dependent kinase activity up to 8 h
ostinfection (p.i.), coincident with an increase in cyclin A
xpression and pRb phosphorylation. However, HSV-2
id not result in elevated levels of cyclin E, and infection
id not induce cells to enter S (Hossain et al., 1997). In a
econd set of studies, the treatment of cells with drugs
eported to inhibit late G1- and S-phase cyclin kinases
esulted in an inhibition of HSV-1 viral replication, viral
NA synthesis, and viral immediate-early (IE) and early
E) gene transcription (Schang et al., 1998, 1999).
Although these results suggest that some G1/S-cyclin
kinase activity is necessary for efficient viral infection
and replication, it has previously been shown that HSV-1
imposes a G1/S block on infected cells. HSV-1 infection
f cells synchronized in G1 prevented progression into S
nd altered the formation of cellular DNA replication
ompartments (de Bruyn Kops and Knipe, 1988). In addi-
ion, the infection of asynchronous cell populations with
SV-1 revealed an accumulation of hypophosphorylated
Rb; an increase in repressive E2F/pRb and E2F/p107
omplexes, which are characteristic of G0- and early
1-phase cells; and a decrease in E2F-dependent re-
orter gene activity (Hilton et al., 1995; Olgiate et al.,
999). Accompanying the increase in repressive E2F–
ocket protein complexes, E2F4 protein translocated to
he nucleus of infected cells and was hyperphosphory-
ated compared with E2F4 of uninfected cells (Olgiate et
l., 1999). Recent investigations with viral mutants sug-
ested a role for ICP0 in HSV-1-induced cell cycle blocks
t both the G1/S and G2/M boundaries (Hobbs and De-
Luca, 1999; Lomonte and Everett, 1999). The viral-in-
duced inhibition of cell cycle progression across the
G1/S boundary and the induction of repressive E2F–
ocket protein complexes prompted us to examine fur-
her the effects of HSV-1 infection on proteins implicated
n regulation of the progression of the mammalian cell
ycle. Specifically, we wanted to directly assay the ef-
ects of viral infection on the activities of cyclin kinases
egulating the G1/S transition.
We examined the effects of HSV-1 infection on the
progression of cell cycle under two cell culture condi-
tions: reentry of quiescent cells into the cell cycle by
mitogenic stimulation and asynchronous growth. G0 cells
that were simultaneously infected and serum stimulated
failed to reenter the cell cycle, whereas uninfected cellsdemonstrated markers of entry and progression through
G1 and S by 20 h after serum stimulation. In contrast, and
consistent with our previous finding of an accumulation
of hypophosphorylated pRb and a decrease in E2F-de-
pendent promoter activity, total CDK2-dependent, cyclin
E-associated, and cyclin A-associated kinase activities
were reduced up to 80% after the infection of asynchro-
nous cell cultures. These results indicate that HSV-1
infection of asynchronously growing cells inhibits the
activities of preexisting G1-cyclin kinases, with conse-
quent effects on pRb phosphorylation and E2F activity,
blocking cell cycle at the G1/S boundary. In addition,
SV-1 infection can prevent the accumulation of cyclin
inase activity at the outset of G1, preventing cell cycle
reentry.
RESULTS
HSV-1 infection of quiescent cells prevents cell cycle
reentry
Our primary aim was to understand the effects of
HSV-1 on mammalian cell cycle, so we first characterized
the effects of HSV-1 infection on progression of cells
from quiescence into G1 phase. Human embryonic lung
HEL) cells are useful for the analysis of virus effects on
ell cycle because they are primary human diploid fibro-
last cells that encode WT pRb and p53 proteins, are
ermissive for HSV-1 infection, and are easily synchro-
ized by serum starvation. We synchronized HEL cells in
0 by serum starvation for 3 days and then induced cell
ycle progression by the readdition of serum. Cells were
ock or HSV-1 infected at the 0-h time point (simulta-
eous with serum addition) and then harvested at vari-
us times after restimulation and assayed for DNA con-
ent by flow cytometry. Figure 1 shows the histograms
enerated by a representative experiment, displaying
NA content at various time points after serum stimula-
ion (Fig. 1A) or serum stimulation and infection (Fig. 1B).
erum stimulated cells displayed a 2 N DNA content at
h, whereas an increase in cells with greater than 2 N
NA content first appeared at 16 h, indicating progres-
ion into S phase (Fig. 1A). By 20 and 24 h, a more
ronounced increase in S phase cells was observed,
nd by 24 h, the appearance of cells in the G2/M phase
had occurred, as indicated by a 4 N DNA content (Fig.
1A). Cells that received HSV-1 simultaneous with serum
addition maintained a 2 N DNA content at all time points
after infection/stimulation (Fig. 1B). The quantitative re-
sults of this experiment are displayed in Table 1 (Exper-
iment 1). Data from two similar experiments are included
(Table 1). These data indicate that in the face of a mito-
genic stimulus, virus-infected cells are unable to
progress from G0/G1 into S phase, consistent with the
observations of de Bruyn Kops and Knipe (1988) that
cells synchronized in M phase by mitotic shake-off are
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337HSV CELL CYCLE EFFECTSunable to progress from G1 to S when infected during G1.
erum-starved cells that were HSV-1 infected without the
eaddition of serum displayed the same inability to
FIG. 1. HSV-1 infection of quiescent cells prevents cell cycle reentry. C
cells were serum starved (0.5% FCS) for 3 days and then (A) released by
released by replacement with medium containing 10% FCS in the pres
by FACS analysis as described in Materials and Methods. The y axis re
ontent.
T
Cell Cycle Profile of Serum Starved HEL Cells After Serums S
Experiment 1
G0/G1 S G2/M
0-h serum 88 8 4
16-h serum 86 13 1
20-h serum 72 28 0
24-h serum 45 36 19
30-h serum 62 24 14
0-h serum 1 HSV-1 87 8 5
16-h serum 1 HSV-1 85 9 6
20-h serum 1 HSV-1 87 9 4
24-h serum 1 HSV-1 87 9 4
30-h serum 1 HSV-1 87 10 3
Note. Subconfluent cultures of HEL cells were serum starved (0.5%
CS in the absence or presence of HSV-1. Cell DNA content and cell cycle p
xperiment 1 provides cell cycle distributions as percentages for the histograrogress out of G0/G1 phase (data not shown). Taken
together, these results suggest that not only does HSV-1
not induce G1/S progression but in fact it inhibits the
e analysis of synchronized/infected cells. Subconfluent cultures of HEL
ement with medium containing 10% FCS. (B) Serum-starved cells were
f HSV-1. Cellular DNA content was determined at the indicated times
ts the number of cells counted, and the x axis represents relative DNA
tion or Serum Stimulation Simultaneous with HSV-1 Infection
Experiment 2 Experiment 3
1 S G2/M G0/G1 S G2/M
3 11 92 8 0
4 10 83 17 0
72 28 0
51 9 51 37 12
32 34 70 25 5
3 13 92 8 0
6 13 94 4 2
94 4 2
11 11 95 3 2
6 13 95 3 2
r 3 days, then released by replacement with medium containing 10%ell cycl
replac
ence oABLE 1
timula
G0/G
86
86
40
34
84
81
76
81
FCS) fo
rofiles were determined as described under Materials and Methods.
ms presented in Fig. 1.
H
w
o
a
A
p
f
M
338 EHMANN, MCLEAN, AND BACHENHEIMERability of mitogenic stimulation to induce such progres-
sion.
Hypophosphorylated pRb accumulates after HSV-1
infection
The assessment of the phosphorylation state of pRb
allows for an additional and specific characterization of
cell cycle status. As reviewed earlier, pRb exists as an
unphosphorylated form in G0 cells, becomes hypophos-
phorylated during mid-G1, and is subsequently hyper-
phosphorylated by late G1. These three forms of pRb are
distinguishable by their different mobilities on a poly-
acrylamide gel, presumably due to the total amount of
phosphorylated serine (and threonine) residues. The
more highly phosphorylated forms of pRb have progres-
sively slower mobilities in SDS–PAGE.
We first assayed the effects of infection on the ability of
FIG. 2. HSV-1 infection of quiescent cells prevents pRb hyperphosph
EL cells were synchronized by serum starvation, restimulated with s
ere harvested at 0, 4, 8, 16, and 20 h after serum stimulation in the pre
f pocket proteins, protein equivalents of nuclear lysates were separa
ntibodies indicated. pRb (DATD) indicates protein separated by DATD
. Cells were restimulated with serum for 12 h and then mock or HSV-1
roteins were performed as described for A. (C) CDK2 was immunoprec
rom synchronized HEL cells as described in the legend to Fig. 1. Kin
aterials and Methods.a synchronized population of cells to generate hyper-
phosphorylated pRb after mitogenic stimulation. Solublecell lysates collected from cells analyzed in the experi-
ment described in Fig. 1 were examined by Western blot
analyses for the levels and relative mobility of pRb. Un-
infected cells, at 12, 16, and 20 h after serum stimulation,
displayed both unphosphorylated and hyperphosphory-
lated forms of pRb (Fig. 2A, pRb panel, lanes 3–5). Cells
stimulated with serum in the presence of HSV-1 infection
failed to induce hyperphosphorylated pRb even as late
as 20 h after stimulation and infection (Fig. 2A, pRb
panel, lanes 6–9). Interestingly, analyses of pRb on a
DATD cross-linked gel resulted in the resolution of four
distinct forms of pRb (Fig. 2A, pRb DATD panel; also see
Song et al., 2000) as opposed to the two forms apparent
on the bisacrylamide cross-linked gels (Fig. 2A, pRb
panel). The DATD gel revealed unphosphorylated pRb in
all lanes and hypophosphorylated and hyperphosphory-
lated pRb in serum-stimulated cells (Fig. 2A, pRb DATD
panel, lanes 1–5). In addition, we saw a virus-specific
n and CDK2-dependent kinase activation. (A) Subconfluent cultures of
nd mock or HSV-1 infected as described in the legend to Fig. 1. Cells
(lanes 6–9) or absence (lanes 1–5) of HSV-1. For Western blot analyses
6% SDS–PAGE, transferred to PVDF membrane, and probed with the
linked 9.25% SDS–PAGE. (B) Cells were synchronized as described for
and harvested at the times indicated. Western blot analyses of pocket
with polyclonal antibody (M2: sc-163) from whole-cell lysates obtained
tivity was determined using histone H1 as substrate as described inorylatio
erum, a
sence
ted by
cross-
infected
ipitated
ase achypophosphorylated pRb with a faster mobility than the
hypophosphorylated pRb found in serum-stimulated
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339HSV CELL CYCLE EFFECTScells (Fig. 2A, pRb DATD panel, lanes 6–9; also see Song
et al., 2000).
As discussed earlier, pRb phosphorylation and the
release and activation of the E2F transcription factor are
dependent on the activity of at least two cyclin kinases:
cyclin D/CDK4 and cyclin E/CDK2. The phosphorylation
of pRb by these two kinases can be distinguished, there-
fore, by antibodies that recognize specific phosphory-
lated residues targeted by cyclin D/CDK4 or cyclin
E/CDK2. pRb residue Ser780 is preferentially phosphor-
ylated by cyclin D/CDK4 (Kitagawa et al., 1996), and pRb
residue Ser811 is preferentially phosphorylated by cyclin
E/CDK2 (Connell-Crowley et al., 1997). We examined the
cyclin D/CDK4-specific and cyclin E/CDK2-specific phos-
phorylation of pRb in mock- or HSV-1-infected cells using
two such phospho-specific antibodies. Both CDK4-spe-
cific (S780) and CDK2-specific phosphorylation (S811) of
pRb appeared by 12 h after serum stimulation (Fig. 2A,
lane 3). CDK4-specific phosphorylation was abundant at
12 h and increased out to 20 h (Fig. 2A, lanes 3–5),
whereas CDK2-specfic phosphorylation appeared at low
levels at 12 and 16 h and was more abundant at 20 h (Fig.
2A, lanes 3–5). Again, phospho-specific pRb antibodies
failed to detect any CDK4-specific or CDK2-specific pRb
phosphorylation in HSV-1-infected cells (Fig. 2A, lanes
6–9). The appearance of high levels of CDK2-dependent
pRb phosphorylation in mock-infected cells corre-
sponded to a time when the proportion of cells in S
phase was increasing (Fig. 1A, Table 1). These phospho-
pRb antibody analyses suggest that both G1-cyclin ki-
nase activities, cyclin D/CDK4 and cyclin E/CDK2, are
inhibited in HSV-1-infected cells. An alternative conclu-
sion is that activities of phosphatases that normally de-
phosphorylate these residues are increased after HSV-1
infection.
To investigate the possibility of an HSV-induced in-
crease in phosphatase activities directed toward pRb,
we examined the effects of HSV-1 infection on synchro-
nized cells that had been allowed to progress sufficiently
into late G1 phase to allow for the presence of some
hyperphosphorylated pRb at the time of infection. If an
increase in phosphatase activity was responsible for the
failure to detect hyperphosphorylated pRb after HSV-1
infection of cells synchronized in G0, then we would
xpect to see a loss of hyperphosphorylated pRb after
SV-1 infection of cells already possessing a population
f phosphorylated pRb. HEL cells were synchronized by
erum starvation, released into medium containing 10%
CS, and infected after 12 h of mitogenic stimulation.
estern blot analyses of pRb protein revealed that at the
2-h time point, approximately 50% of pRb had the hy-
erphosphorylated mobility (Fig. 2B, pRb panel, lane 2).
ith additional incubation in serum alone, the proportion
f hyperphosphorylated pRb increased (Fig. 2B, lanes
–6). After the addition of HSV-1 at 12 h after serum
ddition, we saw that the amount of hyperphosphory- lated pRb present at 8 and 12 h p.i. (20 and 24 h of serum)
eflected that generated by the 12-h time point (Fig. 2B,
ompare lanes 7 and 8 with lane 2), ruling out the
ossibility of virus-induced phosphatase activity targeted
oward pRb. At 16 h p.i. (28 h of serum), we observed a
eneral decrease in the amount of pRb, without effects
n the proportion of phosphorylated and unphosphory-
ated forms (Fig. 2B, lane 9). Our data indicate that in
ynchronized cell populations, HSV-1 infection prevented
he accumulation of hyperphosphorylated forms of pRb
eflecting a disruption in G1/S progression and inhibition
of the activities of the G1-cyclin kinases, cyclin D/CDK4
nd cyclin E/CDK2.
SV-1 prevents p130 hyperphosphorylation and p107
ccumulation in synchronized cells
Pocket proteins p130 and p107 are members of the
Rb protein family, and like pRb, they are important for
ell cycle progression as they target and repress the E2F
ranscription factors. During quiescence, p130/E2F4
omplexes prevail, but as cells cycle into late G1 and
pproach the G1/S boundary, p107 and pRb replace p130
n E2F4 complexes (Moberg et al., 1996). Also like the
pRb protein, p130 and p107 are regulated by the activi-
ties of G1-cyclin kinases (Beijersbergen et al., 1995).
Having shown that infection caused a block in cell cycle
progression of cells synchronized in G0 and inhibition of
pRb phosphorylation, we next investigated the effects of
HSV infection on the abundance and phosphorylation
status of p130 and p107.
HEL cells were synchronized as described earlier
and stimulated to reenter the cell cycle by the addition
of 10% FCS in the presence or absence of HSV-1.
Western blot analyses of cells harvested at various
times after stimulation/infection revealed the follow-
ing. First, p130 was readily detectable in the nucleus
of G0 cells (Fig. 2A, lane 1). As cells progressed
hrough cell cycle, p130 became hyperphosphorylated
nd protein levels decreased (Fig. 2A, lanes 1–5),
hich is consistent with earlier analyses in which
130 became hyperphosphorylated and degraded as
ells approached the G1/S boundary (Smith et al.,
1996). Infection of cells in G0, simultaneous with serum
ddition, prevented p130 hyperphosphorylation, and
he level of nuclear p130 protein remained unchanged
Fig. 2A, lanes 6–9). When cells were allowed to
rogress into late G1 phase and then infected at 12 h
after serum stimulation, hyperphosphorylation and
degradation of p130 were still prevented (Fig. 2B, com-
pare lane 2 with lanes 7–9).
Second, in serum-stimulated cells, p107 was not de-
tectable in nuclei until late G1 (12 h after serum addition),
and levels increased steadily thereafter (Fig. 2A, lanes
1–5). Infection with HSV-1 at G0 prevented the accumu-
ation of p107, even after 20 h of serum stimulation (Fig.
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340 EHMANN, MCLEAN, AND BACHENHEIMER2A, lanes 6–9). Cells infected after 12 h of serum stimu-
lation contained a low level of p107; however, as infec-
tion progressed, the level of p107 declined (Fig. 2B, lanes
7–9). Thus HSV-1 infection prevents the hyperphospho-
rylation and degradation of p130, as well as the late G1
phase accumulation of p107. Both of these results sup-
port the observation that HSV-1 infection prevented cell
cycle reentry of cell populations that were infected dur-
ing G0.
SV-1 infection of quiescent cells prevents activation
f G1-cyclin kinases
Results of FACS analysis and pRb Western blots indi-
cated that HSV-1-infected quiescent cells did not
progress through G1 and across the G1/S boundary.
hese data, especially the reduction in cyclin D-specific
nd cyclin E-specific pRb phosphorylation, suggested
hat the activation of the G1-cyclin kinases was inhibited
y HSV-1. We therefore wanted to corroborate the results
f our phospho-pRb Western blots, suggesting inhibition
f both G1-cyclin kinases, with direct analysis of CDK2
inase activity by immunocomplex kinase assays.
HEL cells were synchronized by serum starvation and
hen released by the readdition of serum in the presence
r absence of virus. Cells were harvested at various
imes after stimulation/infection. CDK2 was immunopre-
ipitated out of equal amounts of protein derived from
hole-cell lysates, and its relative kinase activity was
etermined by in vitro kinase assay using histone H1 as
ubstrate. In the absence of virus, CDK2 kinase activity
as apparent at low levels at 16 h poststimulation (3-fold
nduction), and this activity peaked at 22 and 24 h post-
timulation (13- and 12-fold induction) (Fig. 2C, lanes 3, 6,
FIG. 3. Western blot analyses of CDK and cyclin proteins. (A) Protein e
lysates (prepared as described for Fig. 2A) were separated by 15% DA
the indicated proteins.nd 7). These kinetics of CDK2 kinase activity are con-
urrent with the observed progression of cells through Shase (24 h) and into G2 phase (30 h) (Fig. 1A) and the
hyperphosphorylation of pRb (Fig. 2A, lanes 3–5). In G0
cells, CDK2 kinase activity was low and did not increase
after mitogenic stimulation in the presence of HSV-1
infection even as late as 30 h after serum stimulation
(Fig. 2C, lanes 1–8).
The phospho-pRb Western blots and cyclin-dependent
kinase assays indicated that HSV-1 infection of G0 cells
revented the activation of both G1-cyclin kinases, cyclin
D/CDK4 and cyclin E/CDK2. An examination of the levels
of relevant proteins revealed that the kinase activity in-
hibition was in large part due to a failure of G0-infected
cells to generate G1-cyclin kinase complexes. We first
examined the nuclear levels of CDK4, CDK6 and cyclin
D1 subunits by Western blot analyses of synchronized
HEL cells that were mock or HSV-1 infected at G0 phase.
All three subunits, but especially cyclin D1, were found to
decrease, relative to mock-infected cells, in the presence
of HSV-1 infection (Fig. 3A, compare lanes 1–5 with lanes
6–9). An analysis of cell equivalent amounts of nuclear
and cytoplasmic extracts revealed that in uninfected qui-
escent cells, all three subunits were largely cytoplasmic,
and on serum stimulation translocated to the nucleus
(Fig. 3B, lanes 1–4). In contrast, CDK4 and CDK6 failed to
localize to the nucleus (Fig. 3B, compare lanes 3 and 4
with lanes 5 and 6), and cyclin D1 decreased to unde-
tectable levels in both the cytoplasm and nucleus of
HSV-1-infected cells (Fig. 3B, lanes 5 and 6). The inhibi-
tion of cyclin D/CDK4,6 kinase activity observed in HSV-
1-infected cells (Fig. 2A), therefore, was likely caused by
a decrease in the amount of cyclin D/CDK4,6 kinase
complex present in those cells (Figs. 3A and 3B) due to
a failure of CDK4 and CDK6 to localize to the nucleus and
nts of nuclear lysates or (B) cell equivalents of cytoplasmic and nuclear
ss-linked SDS–PAGE, transferred to PVDF membrane, and probed forquivalea general loss of cyclin D1 protein.
We next asked whether the cyclin E/CDK2 activity was
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341HSV CELL CYCLE EFFECTSdown-regulated in the same manner by examining the
nuclear levels of CDK2 and cyclin E in mock- or HSV-1-
infected, synchronized HEL cells. CDK2 was present in
G0 cells and increased in abundance with mitogenic
stimulation (Fig. 3A, lanes 1–5). When virus was added
concurrently with serum, less nuclear CDK2 accumu-
lated (Fig. 3A, lanes 6–9). An analysis of both cytoplasmic
and nuclear fractions of mock- or G0-infected HEL cells
revealed that although serum stimulation resulted in the
nuclear translocation of CDK2 (Fig. 3B, lanes 1–4), CDK2
failed to translocate to the nucleus in HSV-1-infected
cells (Fig. 3B, lanes 5 and 6). Low levels of nuclear cyclin
E protein were present in G0 cells, peaked at 12 h after
itogenic stimulation, and then declined as cells en-
ered S phase (Fig. 3, lanes 1–5, and Fig. 1A). In addition,
ccumulation of nuclear cyclin A began at 12 h and
ontinued through 20 h of serum, consistent with its role
n regulation of S phase CDK2 activity (Fig. 3A, lanes
–5). After virus infection, nuclear levels of both cyclin E
nd cyclin A did not rise with serum stimulation (Fig. 3A,
anes 6–9). An analysis of both cytoplasmic and nuclear
ractions revealed that the decrease in cyclin E and
yclin A in infected cells was due to a failure to up-
egulate these proteins, rather than a disruption in cel-
ular localization (Fig. 3B, compare lanes 3 and 4 with
anes 5 and 6). It appears that two effects of HSV-1
nfection contributed to the resulting inhibition of cyclin
/CDK2 kinase activity in G0 infected cells. First, the
catalytic subunit of the kinase, CDK2, failed to translo-
cate to the nucleus where the regulatory (cyclin) subunit
resides. Second, HSV-1 infection prevented the up-reg-
ulation of the cyclin E component of the kinase, probably
due to the failure of G0 infected cells to phosphorylate
pRb and release the E2F transcription factor, which is
involved in the cyclin E positive feedback loop. Hence,
the inhibition of these two events resulted in less kinase
complex forming in the nucleus of virus-infected cells.
Infection of asynchronous cells results in a loss of
hyperphosphorylated pRb
Our experiments to this point indicated that HSV-1
infection of quiescent cell populations inhibited cell cy-
cle reentry as marked by the failure to observe events
indicative of G1 phase and G1/S progression. What effect,
then, would HSV-1 infection have on cycling cells ex-
pressing cyclin kinase activities? We endeavored to
characterize the effects of infection on asynchronously
cycling populations of cells to answer this question.
We demonstrated previously that although pRb found
in the nucleus of asynchronous cultures of U2OS cells
existed in a predominantly hyperphosphorylated state,
infection of cells with HSV-1 resulted in a shift to pre-
dominantly hypophosphorylated and unphosphorylated
pRb (Olgiate et al., 1999). U2OS cells express WT pRb
and p53 proteins. Although it has been shown that these
o
acells encode an ICP0-complementing function (Yao and
Schaffer, 1995), this should not obscure observations of
the effects of WT HSV-1 infection. The state of pRb
phosphorylation in nuclear extracts derived from asyn-
chronous cultures of U2OS cells was compared with that
of whole-cell extracts from synchronized HEL cells that
were harvested at 0 h post-serum stimulation (G0 phase,
unphosphorylated pRb) and 18 h post-serum stimulation
(S phase, hyperphosphorylated pRb) (Fig. 4A, lanes 1
and 2). Analyses of Western blots with phospho-specific
pRb antibodies (as described earlier) confirmed that both
the cyclin D/CDK4 (S780)- and the cyclin E/CDK2 (S811)-
dependent phosphorylation of pRb was inhibited or re-
duced after HSV-1 infection of asynchronous U2OS cells
(Fig. 4A). Quantification of band intensity by laser densi-
tometry revealed that the pRb Ser780 phosphorylation of
the infected sample (Fig. 4A, lane 4) was reduced to 33%
of the phosphorylation of the mock-infected sample (lane
3), whereas the pRb Ser811 phosphorylation of the in-
fected sample (Fig. 4A, lane 4) was reduced to 23% of the
phosphorylation of the mock-infected sample (lane 3).
These results are significant compared with the fact that
the total amount of nuclear pRb protein remained un-
changed between the mock-infected and the infected
cell extracts (data not shown, see Olgiate et al., 1999).
hese results further indicate that in asynchronously
rowing cell populations, HSV-1 infection resulted in a
et loss of pRb phosphorylation, representing a loss in
oth cyclin D/CDK4 and cyclin E/CDK2 kinase activities.
he cell cycle perturbation suggested by the decrease in
he proportion of cells containing hyperphosphorylated
Rb after HSV-1 infection was reflected in a disruption in
he cell cycle distribution of the culture. FACS analysis of
synchronously growing U2OS and HEL cells treated
ith phosphonoacetic acid, an inhibitor of the viral DNA
olymerase, revealed that HSV-1 infection resulted in an
ncrease in the proportion of cells in G1, a decrease in
the proportion of cells in G2, and no change in the
roportion of cells in S compared with uninfected, phos-
honoacetic acid-treated cells (data not shown).
SV-1 infection results in the rapid inhibition of
reexisting cyclin E/CDK2 and cyclin A/CDK2
inase activities
We next characterized the effects of virus on G1-cyclin
inase activity preexisting in the asynchronous popula-
ion of cells. Immunoprecipitations for CDK2 were per-
ormed on protein equivalent aliquots of whole-cell ex-
racts derived from mock-infected or HSV-1-infected C33,
2OS, and HEL cells. The level of CDK2 kinase activity
as assayed using histone H1 as substrate. In all three
ell types, we observed a reduction in CDK2 kinase
ctivity after 8 h of HSV-1 infection (Fig. 4B). The analysis
f the human cervical carcinoma cell line, C33, was
dded in these assays to extend our previous analyses
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342 EHMANN, MCLEAN, AND BACHENHEIMERof the effects of HSV-1 on cell cycle activities in this cell
line (Hilton et al., 1995). The use of C33 cells additionally
provides an opportunity to examine the effects of HSV-1
infection on a cell type that encodes mutant forms of pRb
and p53. Kinase assays of immunoprecipitates in the
presence of competing CDK2 peptide, and on samples
with no antibody added, resulted in no detectable kinase
activity, confirming the specificity of our antibody for
CDK2 kinase activity alone and the absence of nonspe-
cific activity precipitating with the agarose beads (data
not shown).
To determine the kinetics of this decline in CDK2
kinase activity after infection, asynchronously growing
U2OS cells were infected, and cultures were harvested
at 2, 4, 6, and 8 h after infection. Again, total CDK2 kinase
activity from mock or infected cell lysates was assayed
using histone H1 as substrate. As early as 2 h p.i., we
observed a reduction in kinase activity, and by 8 h p.i.,
the kinase activity was reduced 80% compared with that
of mock-infected cells (Fig. 4C, lane 5). Over the same
time period, levels of cyclin E and CDK2 protein re-
FIG. 4. Decrease in hyperphosphorylated pRb- and CDK2-dependent
(A) Western blot analyses of nuclear pRb. Asynchronously growing U2
nuclear lysates were separated by 6% SDS–PAGE, transferred to PVD
extracts from synchronized HEL cells harvested in G0 phase (serum
eferences for unphosphorylated and hyperphosphorylated pRb mobi
hole-cell lysates derived from asynchronous HEL, C33, and U2OS cell
s described in Materials and Methods using histone H1 as substrate
nd 8 h p.i. CDK2 was immunoprecipitated from whole-cell extracts, a
lanes 1 and 2), cyclin E (lanes 3 and 4), or cyclin A (lanes 5 and 6) was
ells harvested 8 h after mock (M) or HSV-1 (I) infection. Kinase ac
synchronously growing U2OS cells were mock (M), HSV-1 (I), or UV
rotein equivalent amounts of whole-cell lysates, and kinase activity wa
f CDK2 and for virus inactivation by UV-irradiation, Western blot analyse
y SDS–PAGE, transferred to PVDF membrane, and probed for CDK2mained unchanged (see later).
To more fully characterize the effects of HSV-1 infec-tion on CDK2 kinase activity, we examined total CDK2,
cyclin E-associated, and cyclin-A associated kinase ac-
tivity immunoprecipitated from U2OS whole-cell lysates
on both histone H1 and the more relevant pRb substrate.
Both cyclin E/CDK2 and cyclin A/CDK2 were dramatically
reduced after infection as assayed (Fig. 4D), suggesting
that HSV-1 may be targeting the CDK subunit specifically,
thus affecting both the G1-phase and S-phase forms of
he kinase. Alternatively, virus-induced inhibition of the
1 kinase may be responsible for the inhibition of the
S-phase form, as cyclin A is dependent on cyclin E/CDK2
kinase activities for its E2F-dependent up-regulation (Liu
et al., 1998).
G1-cyclin kinase inhibition in asynchronous cells is
dependent on HSV-1 gene expression
To determine whether viral gene expression was nec-
essary for the HSV-1-induced inhibition of CDK2 kinase
activities, we used UV-irradiated virus to infect cells and
assay for CDK2 kinase activity. UV-irradiated HSV-1 can
activities in asynchronously growing cell cultures infected with HSV-1.
ls were mock (M) or HSV-1 (I) infected for 8 h. Protein equivalents of
brane, and probed for phospho-specific pRb as indicated. Whole-cell
, lane 1) or S phase (18h after serum stimulation, lane 2) served as
Immunocomplex kinase assay. CDK2 was immunoprecipitated from
ere mock (M) or HSV-1 (I) infected for 8 h. Kinase activity was assayed
OS cells were mock (M) or HSV-1 (I) infected and harvested at 2, 4, 6,
se activity was determined using histone H1 as substrate. (D) CDK2
precipitated from whole-cell lysates derived from asynchronous U2OS
as determined using both histone H1 and GST-Rb as substrate. (E)
ted HSV-1 (UV) infected for 8 h. CDK2 was immunoprecipitated from
mined using histone H1 as substrate (top panel). As controls for levels
performed. Equal protein amounts of whole-cell lysate were separated
panel) and ICP4 (bottom panel).kinase
OS cel
F mem
starved
lity. (B)
s that w
. (C) U2
nd kina
immuno
tivity w
-irradia
s deterbind to cell surface receptors and enter the cell but is
unable to express viral genes. Asynchronously growing
aH
d
343HSV CELL CYCLE EFFECTScultures of U2OS cells were either mock-infected, in-
fected with WT HSV-1, or infected with UV-irradiated
HSV-1. Cells were harvested after 8 h of infection, and
equal amounts of protein derived from whole-cell lysates
were evaluated for CDK2 kinase activity. Infection with
UV-irradiated virus failed to reduce CDK2 kinase activity
as seen in cells infected with WT HSV-1 and maintained
levels of CDK2 kinase activity comparable to that of the
mock-infected cells (Fig. 4E, compare lanes 1 and 3).
Western blot analyses were performed on aliquots of
whole-cell extracts. The blots were then probed for IE
viral protein ICP4 to confirm that UV-irradiated virus was
impaired in viral gene expression (Fig. 4E). Indeed, only
minimal amounts of ICP4 were detected in cells infected
with the UV-irradiated virus. This residual amount of viral
protein synthesis may have been due to a low level of
replication-competent virus that was not inactivated. Al-
ternatively, the low level of ICP4 detected may represent
virion-associated protein (Yao and Courtney, 1989). The
levels of CDK2 protein were assayed to confirm that the
effects on CDK2 kinase activity were not due to a loss of
CDK2 protein or unequal protein loading (Fig. 4E). These
results suggest that the virus-induced inhibition of CDK2
kinase activity requires the expression of one or more
viral genes and that a virion protein or proteins alone are
not sufficient to impose the block to G1-cyclin kinase
ctivity.
SV-1 infection of asynchronous cells does not
isrupt cyclin kinase complexes
Having established that preexisting G1-cyclin kinase
activity was inhibited in asynchronous cells infected with
HSV-1, we wanted to understand by what mechanism
kinase inhibition was occurring. Because one major de-
terminant of CDK activity is the availability of cyclin and
CDK subunits in the nucleus where the kinase complex
assembles, we considered whether HSV-1 may be af-
fecting the levels of cyclin or CDK subunits, the intracel-
lular localization of the subunits, or the stability of the
cyclin–CDK complexes.
We examined the levels of CDK2, cyclin E, and cyclin
A proteins in mock- or HSV-1-infected, asynchronously
growing U2OS and C33 cells. Although CDK2 kinase
activity decreased 80% by 8 h p.i. (Fig. 4B), CDK2 and
cyclin protein levels remained intact (Fig. 5A). These
results suggested that unlike the case for G0-infected
cells, the inhibition of CDK2 kinase activity was not due
to the limited availability of cyclin or CDK subunits. In
addition, we determined whether the cellular localization
of the cyclin and CDK2 subunits was altered after infec-
tion. Asynchronously growing C33 cells were harvested
and then fractionated. The cellular localization of the
cyclin and CDK2 subunits was examined by Western blot
analyses of cytoplasmic and nuclear fractions and found
to be unchanged after infection (Fig. 5B).In addition, the decrease in CDK2 kinase activity may
have resulted from a decrease in cyclin–CDK complexes.
To assess cyclin–CDK complex stability, we immunopre-
cipitated CDK2 from whole-cell lysates of mock- or HSV-
1-infected U2OS cells, performed Western blot analyses,
and then probed the blots for cyclin E or cyclin A, as
indicated. The coimmunoprecipitation analyses showed
that the levels of cyclin E and cyclin A associated with
CDK2 did not change after HSV-1 infection (Fig. 5C). This
result indicates that the virus had not altered the stability
of the cyclin–CDK2 complexes or prevented the assem-
bly of those complexes.
Conversely, Western blot analyses of whole-cell ly-
sates derived from asynchronously growing C33 and
U2OS cells showed that the levels of cyclin D1 decline in
HSV-1-infected cells compared with that of mock-in-
fected cells (data not shown.) This suggests that the loss
of cyclin D1/CDK4-specific phosphorylation of pRb (Fig.
FIG. 5. HSV-1 infection of asynchronous cells does not disrupt cyclin
kinase complexes or induce CKIs. Asynchronous subconfluent cultures
of C33 and U2OS cells were mock (M) or HSV-1 (I) infected and
harvested at 8 h p.i. (A) Western blot analyses of CDK, cyclin, and CKI
proteins. Protein equivalent amounts of whole-cell extracts were sep-
arated by SDS–PAGE, transferred to PVDF membrane, and probed for
the indicated proteins. (B) Cyclin–CDK complex stability. Cyclin–CDK
complexes were immunoprecipitated from protein equivalent amounts
of whole-cell extracts. Immunocomplexes were separated by SDS–
PAGE and transferred to PVDF membrane. Cyclin A–CDK2 and cyclin
E–CDK2 complexes were detected by probing for the indicated cyclin
proteins. (C) Intracellular localization of cyclin–CDK subunits in C33
cells. Cytoplasmic (C) and nuclear (N) fractions were made from mock
and infected cell lysates of asynchronous C33 cells. Fractionated
extracts were separated by SDS–PAGE, transferred to PVDF mem-
brane, and probed for the indicated proteins.4A) after HSV-1 infection of asynchronous U2OS cells
was due to a loss of cyclin D1/CDK4,6 kinase complexes.
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344 EHMANN, MCLEAN, AND BACHENHEIMERCDK inhibitor levels in HSV-1-infected cells
Because the activity of cyclin-dependent kinases can
be negatively regulated by direct association with CDK-
inhibitors (CKIs), we examined the level of relevant CKIs
in mock and infected C33 and U2OS cells. We hypothe-
sized that HSV-1 might be down-regulating CDK2 kinase
activity by inducing the CIP/KIP family of CKIs. Western
blot analyses of protein lysates from asynchronous, sub-
confluent cell cultures (Fig. 5A) demonstrated that CDK2
inhibitors p21CIP1/WAF1 and p27KIP1 were not induced by HSV
nfection. In C33 cells, p21 levels were undetectable,
hereas p27 levels remained unchanged. In U2OS cells,
21 levels remained unchanged and p27 levels declined
fter infection. In U2OS cells, the level of WT p53 was
naffected by infection (data not shown). Thus the levels
f relevant CKIs in mock and infected cells do not sug-
est their involvement in the observed inhibition of CDK2
ctivity. The pocket proteins p107 and p130 are also
nown to bind and inhibit cyclin A or E/CDK2 activities
Castan˜o et al., 1998; De Luca et al., 1997; Woo et al.,
997; Zhu et al., 1995). Cycling cells possess low levels of
p130, whereas p107 is abundant. By Western blot anal-
yses of asynchronously growing C33 cells, we found that
the levels of p107 remained unchanged after infection
(Fig. 5A). The implications of this finding for CDK2 regu-
lation are discussed later.
DISCUSSION
In this study, we investigated the effects of HSV-1
infection on cell cycle progression; the status of cell
cycle regulatory proteins, including the retinoblastoma
family; and the activities of G1-specific cyclin-dependent
kinases cyclin D/CDK4,6 and cyclin E/CDK2. After the
infection of growth-arrested cells simultaneous with the
readdition of serum, we observed that HSV-1 infection
resulted in the persistence of a hypophosphorylated
form of pRb, inhibition of cyclin D/CDK4-specific and
cyclin E/CDK2-specific phosphorylation of pRb serine
residues, and failure to detect CDK2-dependent kinase
activities. In addition, there was a failure to hyperphos-
phorylate and degrade p130, accompanied by a failure to
accumulate p107. These results, along with our flow
cytometry data, suggest that when infected with HSV-1,
G0 cells fail to reenter the cell cycle even in the presence
of mitogenic stimulation. By infecting asynchronous cell
populations, we detected rapid inhibition of G1- and S-
phase CDK2-dependent kinase activity and found this
inhibition to be independent of the pRb and p53 status of
the cell. Coupled with our previous observations that
hypophosphorylated pRb accumulated, E2F activity de-
creased, and cellular DNA synthesis was rapidly inhib-
ited after infection (Olgiate et al., 1999), we conclude that
HSV-1 can block cell cycle progression at the restriction
point near the G1/S boundary and also in S phase.
Previously, de Bruyn Kops and Knipe (1988) showedthat the infection of cells in G1 phase prevented the
rogression of cells into S phase. Infection of cells dur-
ng S, although resulting in the same number of cells
abeled with bromodeoxyuridine (BrdU) as uninfected
ontrols, resulted in a decrease in the level of DNA
ynthesis. Similarly, we have seen that cells infected in
ate G1 appeared to enter S but were unable to complete
DNA replication as measured with flow cytometry (G. L.
Ehmann and S. L. Bachenheimer, unpublished observa-
tions; Olgiate et al., 1999). It appears, therefore, that
HSV-1 infection results in a halt to cell cycle progression
regardless of whether the cells have transitioned
through G1. Indeed, infection of asynchronous popula-
ions of cells resulted in a general decrease in G1- and
-specific cyclin kinase activities, revealing that regard-
ess of the status of the cell at the time of infection, cyclin
inase inhibition ensues.
Given these observations, it is interesting to speculate
s to how virus infection leads to a cell cycle block in any
iven phase. For example, the infection of quiescent
ells resulted in the failure to target and degrade p130
nd to accumulate p107. It is unclear whether the reten-
ion of p130 and prevention of p107 induction is a result
f the cell cycle block or a mechanism by which the virus
ccomplishes the block. Indeed, when cells are in a
uiescent state, p130 abounds. This population of p130
ust be targeted for degradation for E2F to be released
nd hence begin transcription of genes necessary for
ell cycle progression. If HSV-1 infection inhibits the
egradation of this pocket protein, cells may be blocked
n a G0-like state. On the other hand, degradation of p130
t the initiation of cell cycle entry requires phosphoryla-
ion by G1-cyclin kinases (Smith et al., 1996). If HSV-1 is
preventing cell cycle progression by inhibiting G1-cyclin
kinase activities, then p130 would persist. This second
possibility is supported by our experiments in which
infection of quiescent cells resulted in the failure of
mitogenic signals to up-regulate cyclin D1 and cyclin E
proteins, resulting in the absence of kinase activity nec-
essary for pRb phosphorylation. The virus could be in-
tervening at any number of points in the regulatory path-
way. Activation of the RAS–RAF–MEK–ERK pathway is
responsible for the up-regulation of cyclin D1 and, con-
sequently, D-type kinases (Aktas et al., 1997). Conversely,
activation of glycogen synthase kinase-3b via a RAS-
dependent pathway involving phosphatidylinositol 3-ki-
nase and Akt (protein kinase B) results in cyclin D1
phosphorylation at Thr286, nuclear export, and subse-
quent ubiquitin-dependent proteasomal degradation
(Sherr and Roberts, 1999). D-type kinases are responsi-
ble for phosphorylation of pRb, the ensuing release of
E2F, and up-regulation of E2F-dependent genes neces-
sary for cell cycle progression, including cyclin E and
cyclin A. We recently reported on the induction of stress-
activated protein kinases JNK and p38 and the absence
of mitogen-activated protein kinase ERK induction
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345HSV CELL CYCLE EFFECTS(McLean and Bachenheimer, 1999) after the infection of
asynchronous cells. Our present work reveals the failure
of quiescent cells to display markers of cell cycle pro-
gression when exposed to growth factors in the pres-
ence of virus, and our future efforts will be directed at
determining where HSV-1 is blocking mitogenic stimula-
tion of cell cycle reentry.
Our finding that HSV-1 infection inhibited both cyclin
E/CDK2 and cyclin A/CDK2 kinase activities differs from
that of an earlier study. It was reported that infection of
serum-starved CV-1 cells by HSV-2 resulted in the tran-
sient induction of CDK2-dependent kinase activity (Hos-
sain et al., 1997). Although these authors reported an
induction of CDK2-dependent kinase activity beginning
at 2 h p.i. that peaked at 8 h p.i., the levels of CDK2
kinase activity in infected cells were still reduced com-
pared with those of serum-stimulated cells, and the ki-
nase activation in infected cells was significantly inhib-
ited compared with that of serum-stimulated cells at 16
and 24 h post-stimulation/infection. Using synchronized
CV-1 cells and HSV-2 strain G, we have been unable to
reproduce the results reported by Hossain et al. (1997)
(data not shown). In addition, Song et al. (2000) report
that infection of CV-1 cells with HSV-2 resulted in the
failure of cells to accumulate hyperphosphorylated pRb
in response to mitogen, suggesting an inhibition of G1-
cyclin kinase activities. In our studies of synchronized
HEL cells, we have never observed an induction of
CDK2-dependent kinase activity after infection with
HSV-1 (G. L. Ehmann and S. L. Bachenheimer, unpub-
lished observation).
One previous report suggested that HSV-1 required
the induction of one or more late-G1/S cyclin-dependent
inase activities to promote viral replication (Schang et
l., 1998). In their study, Schang et al. (1998) presented
vidence that viral DNA replication and viral RNA tran-
cription were reduced in the presence of the cell cycle-
nhibiting drugs roscovitine and olomoucine. These au-
hors concluded that HSV-1 requires one or more CDK
ctivities present during G1 and beyond that are inhibited
y these drugs (including CDK1, CDK2, or CDK5). How-
ver, no assay for the effects of roscovitine or olo-
oucine on levels of CDK kinase activity in normally
ycling, mock- or HSV-1-infected cells was presented.
The results presented here plus those of additional
tudies conducted in our laboratory indicate that, in fact,
SV-1 may inhibit G1-cyclin kinase activity to create an
nvironment favorable to virus replication. The infection
f cells ectopically overexpressing cyclin E and CDK2
rom adenovirus vectors resulted in a 90% reduction in
irus yield. The coexpression of the CDK2 inhibitor p21
ith cyclin E and CDK2 resulted in the recovery of virus
roduction to WT levels (S. L. Bachenheimer and G. L.
hmann, unpublished observation).Our assays indicated that both cyclin D/CDK4,6 and
yclin E/CDK2 kinase activities were inhibited as a result
p
pf infection of both synchronized G0 cells and asynchro-
nously growing cells. An examination of the protein lev-
els of these kinase complexes revealed two potentially
different mechanisms for inhibition of the kinases. West-
ern blot analyses of proteins from synchronized cells
demonstrated that cyclin E and especially cyclin D1
declined after HSV-1 infection. In addition, CDK4, CDK6,
and CDK2 did not translocate to the nucleus of infected
cells. In agreement with our data, Song et al. (2000)
report that G0 infection of synchronized CV-1 cells with
HSV-2 resulted in the failure to accumulate cyclins D1
and D3, no effect on the levels of cyclin D2, and failure to
accumulate G1-specific forms of CDK4 and CDK2. We
conclude that the failure to accumulate cyclin D1 and
cyclin E, coupled with the failure of all three CDKs to
translocate to the nucleus, resulted in a decrease in
kinase complex formation and therefore a failure to de-
tect kinase activity by phospho-pRb Western blots or
immunocomplex kinase assays. However, in the second
system we investigated, infection of asynchronously
growing cells, we observed rapid inhibition of preexist-
ing cyclin E/CDK2 kinase activity but without a loss of
cyclin/CDK subunits or complexes.
CDK2 protein level remains constant while its activity
fluctuates throughout the cell cycle. At the present, it is
clear that CDK2 kinase activity is controlled by (1) the
availability of corresponding cyclin subunits (Morgan,
1995), (2) its intracellular localization (Bresnahan et al.,
1996), (3) the phosphorylation state of Thr160, Thr14, and
Tyr15 (DeBondt et al., 1993; Gu et al., 1992; Poon and
unter, 1995; Sebastian et al., 1993), (4) the binding
toichiometry of associated CKIs of the CIP/KIP family
Chen et al., 1995; LaBaer et al., 1997; Zhang et al., 1994),
nd (5) its association with the pocket proteins p107 and
130 (Castan˜o et al., 1998; De Luca et al., 1997; Hauser
t al., 1997; Woo et al., 1997). As reported earlier, Western
lot analyses revealed that neither the protein levels nor
he intracellular localization of the CDK2, cyclin E, and
yclin A subunits was affected in asynchronous cells
fter infection. However, cyclin D1 levels were lower in
SV-1-infected cells compared with mock-infected cells.
mmunoprecipitation/Western blot analyses confirmed
hat cyclin/CDK complexes remained intact after infec-
ion. Thus HSV-1 does not appear to be targeting the
ormation or stability of the preexisting cyclin–CDK com-
lexes. One explanation for the stability of cyclin E rela-
ive to cyclin D1 may be that targeting of cyclin E for
biquitin-dependent degradation is regulated by auto-
hosphorylation (Clurman et al., 1996; Won and Reed,
996). Thus loss of cyclin E/CDK2 kinase activity in HSV-
-infected cells may stabilize existing cyclin E protein.
In addition, we have been unable to detect any change
n the amount of CDK2-associated tyrosine phosphory-
ation as judged by Western blot analyses with anti-
hosphotyrosine antibody on immunoprecipitated CDK2
rotein (G. L. Ehmann and S. L. Bachenheimer, unpub-
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346 EHMANN, MCLEAN, AND BACHENHEIMERlished observation). Western blot analyses of related
CKIs, p21 and p27, showed that levels of these CDK
inhibitory proteins did not increase after HSV-1 infection.
However, the binding stoichiometry of CKI to CDK deter-
mines whether these interactions are inhibitory. For ex-
ample, it is thought that two molecules of p21 are re-
quired to inactivate a cyclin/CDK2 kinase (Zhang et al.,
1994), whereas a 1:1 ratio may be required for cyclin—
CDK complex formation. We have not yet assessed the
binding stoichiometry of the CKI–CDK2 interactions in
HSV-1-infected cells, and the possibility of an increase in
the ratio of p21 to CDK2 in complexes remains a poten-
tial mechanism of CDK2 inhibition to explore.
We reported previously that infection of asynchro-
nously growing cells with HSV-1 results in the accumu-
lation of E2F complexes containing the pocket protein
p107 and cyclin A/CDK2 (Hilton et al., 1995; Olgiate et al.,
1999). An increase in this complex may explain the de-
crease in CDK2 kinase activity that we observed, be-
cause previous reports had indicated that CDK2 activity
bound to p107 and p130 was inactive (Castan˜o et al.,
1998; Woo et al., 1997). However, on further analyses of
p107 and its association with CDK2 after HSV-1 infection,
we found that the total level of p107 within asynchro-
nously growing cells was not changed after infection.
Furthermore, the amount of CDK2 that coimmunoprecipi-
tated with p107 remained unchanged in infected cells
(G. L. Ehmann and S. L. Bachenheimer, data not shown).
One possible explanation for these results is that the
accumulation of E2F complexes containing p107 and
cyclin A/CDK2 seen in infected asynchronous cell pop-
ulations is actually due to the inhibition of CDK2 kinase
activity. In uninfected cells, active CDK2 is bound to and
phosphorylates p107, preventing recruitment of E2F. As
HSV-1 infection progresses, phosphorylation of p107 by
bound CDK2 decreases as CDK2 kinase activity is down-
regulated. Hypophosphorylated p107 accumulates and is
subsequently recruited to E2F, which can be monitored
by an E2F-dependent gel shift assay. This model is also
supported by the observation that hypophosphorylated
pRb (Olgiate et al., 1999) and hypophosphorylated p130
ersist after infection, coincident with an increase in
2F–pRb complexes (Olgiate et al., 1999) and the persis-
ence of E2F–p130 complexes (G. L. Ehmann and S. L.
achenheimer, unpublished observation).
To investigate the role of virus-encoded proteins in the
bserved cell cycle disruptions, we determined whether
iral gene expression was necessary for the inhibition of
DK2 kinase activity. Cells infected with UV-irradiated
SV-1 displayed no loss of CDK2 kinase activity. We
uspect that one or more IE gene is responsible for the
inase inhibition, because CDK2 kinase activity declines
s early as 2 h after infection, a time when only IE genes
re being expressed. Indeed, recent studies by Hobbs
nd DeLuca (1999) and Lomonte and Everett (1999) in-
icated a role for IE gene product ICP0 in a viral-induced sG0/G1, as well as a G2/M, cell cycle block. Using a panel
of mutant viruses, we will perform further analyses of the
roles of IE gene products in the disruption of G1-cyclin
inases and the prevention of G1/S progression.
MATERIALS AND METHODS
ells and virus
Human cervical carcinoma C33 cells (ATCC HTB31;
ut p53 and mut pRb; American Type Culture Collection,
ockville, MD), human osteosarcoma (U2OS) cells (ATCC
TB96; WT p53 and WT pRb), and HEL fibroblast 299
ells (ATCC CCL137; WT p53 and WT pRb) were main-
ained in DMEM-H, supplemented with 10% FCS. HSV-1
train KOS 1.1 was used for all experiments. Unless
therwise specified, all infections were performed at a
ultiplicity of infection (m.o.i.) of 5 PFU/cell.
ell synchronization and FACS analysis
Subconfluent cultures of HEL cells were synchronized
n G0 phase by serum starvation. Cell monolayers were
washed once with serum-free medium and then overlaid
with medium containing 0.5% FCS and incubated at 37°C
for 3–4 days. Starved cells were restimulated with me-
dium containing 10% FCS in the presence or absence of
HSV-1 and then harvested at various time points postre-
stimulation.
Cells were harvested by trypsinization and pelleted
through 1 ml of calf serum. Cell pellets were then
washed once with 13 PBS. Some cell pellets were pro-
cessed to yield soluble protein lysates for Western blot
analysis, as described later. Cells for FACS analysis
were washed with 5 ml of 13 PBS, repelleted, and then
resuspended in 1 ml of 13 PBS. Cells were then fixed
with the slow addition of 4 ml of ice-cold 95% ethanol and
stored at 220°C. At least 2 3 106 fixed cells were
pelleted and washed with 5 ml of 13 PBS–1% BSA. Cells
were pelleted again and then resuspended in 500 ml of
RNase A solution (1.12% Na citrate, 20 mg/ml RNase A)
nd 500 ml PI solution (1.12% Na citrate, 50 mg/ml pro-
pidium iodide, 0.1% Triton X-100) and transferred to Fal-
con 2054 tubes. DNA content was determined using an
FACScan instrument (Becton Dickinson (San Jose, CA).
Cell cycle profile was determined by analysis of listmode
data with ModFit software.
Preparation of cell extracts
To prepare whole-cell extracts, cells were harvested
by being scraped into medium and rinsing the plate with
5 ml of 13 PBS. Cells were pelleted and then washed
twice with 13 PBS. Cell pellets were resuspended in
0.2% Tween 20 lysis buffer (50 mM HEPES, pH 7.3, 150
mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.2% Tween 20
with 1 mM DTT, 1 mM PMSF, 1mg/ml aprotinin, 1 mM
odium orthovanadate, 10 mM b-glycerophosphate, and
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347HSV CELL CYCLE EFFECTS1 mM NaF) and lysed for 4–5 h at 4°C. Cellular debris
was removed by centrifugation for 10 min at 12,000 3 g
t 4°C. The supernatant was recovered and stored at
70°C.
Fractionated cytoplasmic and nuclear extracts were
repared by a rapid lysis protocol. Cells were harvested
y trypsinization and pelleted through 1 ml of bovine calf
erum. Cell pellets were washed twice in 13 PBS and
esuspended in 3 packed cell volumes (PCV) of CE buffer
10 mM HEPES, pH 7.8, 1 mM EDTA, 60 mM KCl, 1 mM
MSF, 0.1% Nonidet P-40, 25% glycerol, 0.4 mM NaF, 0.4
M sodium orthovanadate, 10 mM pepstatin, and 4%
Complete Protease Inhibitor Cocktail (Boehringer-Mann-
heim Biochemicals, Indianapolis, IN)]. Cells were incu-
bated on ice for 4 min, and then nuclei were spun out
with a 10-s spin in a bench top microfuge. The superna-
tant was recovered and clarified by centrifugation at
12,000 3 g for 10 min at 4°C. The recovered supernatant
as the cytoplasmic extract. Pelleted nuclei were resus-
ended in CW buffer (same as CE buffer, except lacking
onidet P-40 and glycerol) and then subjected to 20
trokes in a 1-ml Dounce homogenizer and then repel-
eted at 12,000 3 g for 10 min at 4°C. The nuclear pellet
as then resuspended in 2 PCV of Moberg (Moberg et
l., 1996) nuclear lysis buffer (0.5 M KCl, 35% glycerol, 100
M HEPES, pH 7.4, 5 mM MgCl2, 0.5 mM EDTA, 5 mM
NaF, 1 mM PMSF, 1 mM DTT, and phosphatase and
protease inhibitors as described for CE buffer). The sus-
pended nuclei were incubated on ice for 10 min and then
pelleted at 60,000 rpm for 20 min at 4°C with a Beckman
TL100.3 rotor. The recovered supernatant represented
the nuclear extract. Both cytoplasmic and nuclear ex-
tracts were stored at 270°C. Protein concentration of all
cell extracts was determined according to the Bradford
assay (Bio-Rad, Hercules, CA).
Detection of proteins
Infected cell proteins were detected by Western blot
analysis. Briefly, aliquots of cell extracts representing
equal total cell protein were mixed with 23 sample
buffer (Harlow and Lane, 1988) and denatured by boiling
for 5 min. Proteins were separated by bisacrylamide
cross-linked (1:37.5) or DATD-acrylamide cross-linked (1:
38) SDS–PAGE and transferred to PVDF membrane (New
England Nuclear, Boston, MA). Membranes were
blocked for 30 min in TBST (50 mM Tris–HCl, pH 7.5, 150
mM NaCl, 0.05% Tween 20) containing 5% nonfat dried
milk. Proteins were detected by incubation with specified
rabbit polyclonal or mouse monoclonal antibody, fol-
lowed by incubation with the appropriate secondary an-
tibody conjugated to horseradish peroxidase. Antibodies
were detected by incubation in Renaissance chemilumi-
nescent reagent (New England Nuclear) and visualized
on Biomax-MR film (Kodak).
Antibodies used for all experiments included CDK2(M2, sc-163), CDK4 (sc-260), cyclin A (BF683, sc-239),
cyclin E [HE111, sc-248 (for immunoprecipitation)], cyclin
E [HE12, sc-247 (for Western blots)], and anti-mouse
IgG-HRP (sc-2005; all from Santa Cruz Biotechnology,
Santa Cruz, CA). The pRb antibody (14001A) was from
PharMingen (San Diego, CA). Phospho-Rb Ser780 (no.
9307S) and phospho-Rb Ser811 (no. 9308S) were from
New England Biolabs (Beverly, MA). Anti-rabbit Ig-HRP
(NA 934) was from Amersham (Arlington Heights, IL).
Cyclin D1 (342) was obtained from Yue Xiong (University
of North Carolina at Chapel Hill). ICP4 (H943) was ob-
tained from Lenore Pereira (University of California at
San Francisco).
Immunoprecipitations
Cell extracts of 100–500 mg of protein were first pre-
leared with protein A agarose beads (Boehringer-
annheim) for 30 min at 4°C. Beads were spun out, and
hen precleared cell extract was incubated with rabbit
olyclonal or mouse monoclonal antibody for 2–15 h at
°C on an orbital mixer. Protein complexes were then
recipitated by incubation with protein A agarose beads
Boehringer-Mannheim) for 1–4 h at 4°C. Precipitated
omplexes were washed three times with 0.2% Tween 20
ysis buffer and then resuspended in 40 ml of sample
buffer and boiled for 5 min. Proteins were separated by
SDS–PAGE and visualized by Western blotting as de-
scribed earlier.
Immunocomplex kinase assays
CdK2-specific cyclin kinase complexes were immuno-
precipitated from 100–500 mg of total cell protein with 10
ml of anti-cdk2 (M2) rabbit antibody, anti-cyclin A (BF683)
mouse monoclonal antibody, or anti-cyclin E (HE111)
mouse monoclonal antibody (Santa Cruz) for 12 h at 4°C
and collected on 20-ml 50% protein A agarose beads
(Boehringer-Mannheim) for 1 h at 4°C. Immunoprecipi-
tates were washed twice with lysis buffer and twice with
kinase buffer (50 mM HEPES, pH 7.3, 10 mM MgCl2) and
esuspended in 25 ml of kinase buffer (containing 1 mM
TT, 1 mM o-Na vanadate, 2.5 mM EGTA, 20 mM ATP, 10
M b-glycerophosphate, 1 mM NaF) with substrate
10–25 mg GST-Rb or 1.5 mg of histone H1) and 5 mCi of
[g-32P]ATP. The kinase reaction was allowed to proceed
or 30 min at 30°C and was stopped by the addition of 25
ml of 23 SDS sample buffer. Samples were boiled for 5
min and then separated by SDS–PAGE. Gels were vac-
uum dried, and phosphorylated substrate was visualized
by autoradiography using BioMax-MR film (Kodak) and
quantified by laser densitometry. Escherichia coli trans-
formed with pGEX-Rb (379-928) was obtained from J.
DeGregori (University of Colorado Health Science Cen-
ter), and GST-Rb substrate was prepared as described
previously (Matsushime et al., 1994).
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348 EHMANN, MCLEAN, AND BACHENHEIMERGeneration of figures
Figures 2–5 were created using Microsoft PowerPoint.
Images of original autoradiograms were generated using
a desktop scanner, saved as Corel PhotoPaint files and
then imported into Microsoft PowerPoint.
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